JAK1 inhibitor superior to abatacept in head-to-head RA trial
Crossref DOI link: https://doi.org/10.1038/s41584-020-00535-5
Published Online: 2020-10-27
Published Print: 2020-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Onuora, Sarah
Text and Data Mining valid from 2020-10-27
Version of Record valid from 2020-10-27
Article History
First Online: 27 October 2020